StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

Equities researchers at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Monday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

TTOO opened at $0.14 on Monday. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80. The firm has a 50 day moving average of $0.23 and a two-hundred day moving average of $0.98.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.